Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators
- PMID: 17386975
- DOI: 10.1016/j.neulet.2007.01.017
Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators
Abstract
Plasminogen activators are used in thrombolytic stroke therapy. However, it is increasingly recognized that they have other actions besides fibrinolysis. In this study, we assess potential pro-inflammatory effects of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) in rat cortical astrocytes. Both uPA and tPA induced rapid dose-dependent upregulation in MMP-2 and MMP-9, as demonstrated by zymography of conditioned media. In addition, a multiplex ELISA array demonstrated that patterned responses in chemokines and cytokines were also evoked. Exposure to tPA induced elevations in secreted MIP-2, MCP-1 and GRO/KC. Exposure to uPA induced elevations in secreted IFN-gamma, TNF-alpha, GMCSF, MIP-1alpha, MIP-2, MIP-3alpha, MCP-1, RANTES and fractalkine. These data suggest that plasminogen activators may trigger selected pro-inflammatory responses at the neurovascular interface. Whether these effects influence thrombolytic stroke therapy warrants further investigation.
Similar articles
-
Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes.Brain Res. 2006 Sep 21;1111(1):222-6. doi: 10.1016/j.brainres.2006.06.041. Epub 2006 Aug 17. Brain Res. 2006. PMID: 16919608
-
Differential inflammatory activation of IL-6 (-/-) astrocytes.Cytokine. 2005 Apr 21;30(2):47-55. doi: 10.1016/j.cyto.2004.11.007. Cytokine. 2005. PMID: 15804595
-
Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.J Neurosci Res. 2003 Nov 1;74(3):430-4. doi: 10.1002/jnr.10786. J Neurosci Res. 2003. PMID: 14598319
-
Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.Stroke. 2004 Nov;35(11 Suppl 1):2726-30. doi: 10.1161/01.STR.0000143219.16695.af. Epub 2004 Sep 30. Stroke. 2004. PMID: 15459442 Review.
-
Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases.J Neurosci Res. 2002 Jul 1;69(1):1-9. doi: 10.1002/jnr.10270. J Neurosci Res. 2002. PMID: 12111810 Review.
Cited by
-
Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.Curr Pharm Des. 2012;18(25):3624-44. doi: 10.2174/138161212802002625. Curr Pharm Des. 2012. PMID: 22574987 Free PMC article. Review.
-
Neuronal and astrocytic interactions modulate brain endothelial properties during metabolic stresses of in vitro cerebral ischemia.Cell Commun Signal. 2014 Jan 17;12:7. doi: 10.1186/1478-811X-12-7. Cell Commun Signal. 2014. PMID: 24438487 Free PMC article.
-
Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.Ann Surg. 2015 Feb;261(2):395-404. doi: 10.1097/SLA.0000000000000602. Ann Surg. 2015. PMID: 24651130 Free PMC article.
-
Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology.Int J Cell Biol. 2012;2012:176287. doi: 10.1155/2012/176287. Epub 2012 Jun 24. Int J Cell Biol. 2012. PMID: 22778741 Free PMC article.
-
Tissue plasminogen activator rescues steroid-induced outflow facility reduction via non-enzymatic action.Mol Vis. 2021 Dec 7;27:691-705. eCollection 2021. Mol Vis. 2021. PMID: 35002214 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous